Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1980-4-23
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0043-3144
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
148-55
|
pubmed:dateRevised |
2008-3-10
|
pubmed:meshHeading |
pubmed-meshheading:575248-Erythroblastosis, Fetal,
pubmed-meshheading:575248-Female,
pubmed-meshheading:575248-Glucosephosphate Dehydrogenase Deficiency,
pubmed-meshheading:575248-Hematologic Diseases,
pubmed-meshheading:575248-Humans,
pubmed-meshheading:575248-Infant, Newborn,
pubmed-meshheading:575248-Methylene Blue,
pubmed-meshheading:575248-Pregnancy
|
pubmed:year |
1979
|
pubmed:articleTitle |
Screening for glucose-6-phosphate dehydrogenase deficiency in haemolytic disorders: the methylene blue reduction test.
|
pubmed:publicationType |
Journal Article
|